Showcases Stock ranks Forex

Novo Nordisk A/S ADR (NVO)
106.01  1.6 (1.53%) 10-22 16:00
Open: 105.43 Pre. Close: 104.41
High: 106.09 Low: 105.39
Volume: 616,471 Market Cap: 243,000M
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharmaceuticals. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company has a strategic alliance with Evotec AG to discover and develop small molecule therapies to treat patients suffering from diabetes, obesity, and co-morbidities, as well as has a research collaboration with Kallyope Inc. It also has collaboration agreements with Lund University to develop stem cell-derived treatment for Parkinson's diseases; Staten Biotechnology B.V. to develop novel therapeutics for the treatment of dyslipidaemia; Medtronic plc to develop integrated digital solutions for people with diabetes; and bluebird bio, Inc. to develop in vivo genome editing treatments for genetic diseases. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 106.143 - 106.666 106.666 - 107.197
Low: 104.139 - 104.691 104.691 - 105.25
Close: 105.13 - 105.997 105.997 - 106.876
Stock Technical Analysis
Target: Six months: 123.91
One year: 144.73
Support: Support1: 99.13
Support2: 94.83
Resistance: Resistance1: 106.09
Resistance2: 123.91
Pivot: 100.68
Moving Averages: MA(5): 104.61
MA(20): 99.63
MA(100): 94.51
MA(250): 80.69
MACD: MACD(12,26): 1.46
Signal(12,26,9): 0.61
%K %D: %K(14,3): 94.26
%D(3): 93.65
RSI: RSI(14): 69.67
52-Week: High: 107.24
Low: 63.22
Change(%): 52.2
Average Vol(K): 3-Month: 102824
10-Days: 78892
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

NVO has closed below upper band by 7.8%. Bollinger Bands are 52.2% wider than normal. The large width of the bands suggest high volatility as compared to NVO's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.
Stock chart
Stock News
Mon, 11 Oct 2021
NVO (Novo Nordisk A/S ADR) -

Mon, 27 Sep 2021
Novo Nordisk A/S – Share repurchase programme - GlobeNewswire

Mon, 09 Aug 2021
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 5 August 2021 - Yahoo Finance

Thu, 05 Aug 2021
Novo Nordisk's (NVO) Q2 Earnings and Sales Beat Estimates - Nasdaq

Wed, 04 Aug 2021
Novo Nordisk's net profit increased by 10% in the first six months of 2021 - GlobeNewswire

Tue, 03 Aug 2021
Here's what Wall Street expects from Novo Nordisk (spons ADRs)'s earnings - Markets Insider

Financial Analysis
Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 2300.00
Shares Float (M) 1640.00
% Held by Insiders 0.01
% Held by Institutions 7.69
Shares Short (K) 3460
Shares Short Prior Month (K) 4160
Stock Financials
EPS 2.950
Book Value (p.s.) 25.330
Profit Margin 34.15
Operating Margin 41.64
Return on Assets (ttm) 23.0
Return on Equity (ttm) 70.6
Qtrly Rev. Growth 10.1
Gross Profit (p.s.) 46.091
Sales Per Share 56.483
EBITDA (p.s.) 25.548
Qtrly Earnings Growth 14.10
Operating Cash Flow (M) 54190.00
Levered Free Cash Flow (M) 22040.00
Stock Valuation
PE Ratio 35.94
PEG Ratio
Price to Book value 4.19
Price to Sales 1.88
Price to Cash Flow 4.50
Stock Dividends
Dividend 9.100
Dividend Yield 0.09
Dividend Growth 1.470

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator